Profil
Dr. Magali Taiel, MD, is a Chief Medical Officer at Gensight Biologics SA. Dr. Taiel was previously employed as a Vice President-Clinical Development by ProQR Therapeutics NV and a Project Manager by Servier SAS. She received her doctorate degree from Universite Paris Cite.
Aktiva positioner av Magali Taiel
| Företag | Position | Start |
|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Teknisk/Vetenskaplig/F&U Direktör | 2019-10-08 |
Tidigare kända positioner av Magali Taiel
| Företag | Position | Slut |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Företagsledare/Principal | 2018-09-01 |
Servier SAS
Servier SAS Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Företagsledare/Principal | 2001-01-01 |
Magali Taiels utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Gensight Biologics SA
Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases | Health Technology |
ProQR Therapeutics NV
ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
Universite Paris Cite
Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Servier SAS
Servier SAS Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
















